Effect of renal impairment on the pharmacokinetics of prucalopride: a single- dose open-label Phase I study
William B Smith,1 Erik Mannaert,2 Tom Verhaeghe,2 René Kerstens,3 Lieve Vandeplassche,3 Vera Van de Velde41Volunteer Research Group and New Orleans Center for Clinical Research, The University of Tennessee Medical Center, Knoxville, TN, USA; 2Janssen Research and Development, a divisi...
Main Authors: | Smith WB, Mannaert E, Verhaeghe T, Kerstens R, Vandeplassche L, Van de Velde V |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-12-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/effect-of-renal-impairment-on-the-pharmacokinetics-of-prucalopride-a-s-a11776 |
Similar Items
-
Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I study
by: Kim S, et al.
Published: (2014-10-01) -
An NMR Study on Prucalopride
by: ZHOU Zhong-gao, et al.
Published: (2018-03-01) -
An update on prucalopride in the treatment of chronic constipation
by: Anam Omer, et al.
Published: (2017-11-01) -
An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients with Treatment Resistant Schizophrenia
by: Ishwary Damodaran, et al.
Published: (2020-12-01) -
Different doses of prucalopride in treating chronic idiopathic constipation: a meta-analysis and Bayesian analysis
by: Kaili Wang, et al.
Published: (2021-02-01)